Testim
- Product NDC
- 66887-001
- 11-digit product format
- 668870001
- Labeler code
- 66887
- Product ID
- 66887-001_366a5e88-4a23-46b0-94e5-e7f7deb7acbe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- testosterone
- Dosage form
- GEL
- Route
- TRANSDERMAL
- Labeler
- Endo USA, Inc.
- Application
- NDA021454
- Marketing category
- NDA
- Marketing start
- 2002-10-31
- Substance
- TESTOSTERONE
- Active strength
- 50 mg/5g
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021454-001 | TESTIM | TESTOSTERONE | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021454-001 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021454-001 | TESTIM | 50MG/5GM PACKET | GEL / TRANSDERMAL | AB2 | RLD, RS | 2002-10-31 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021454-001 | AB2 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021454-001 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021454-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021454-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021454-001 | AB2 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021454-001 | AB2 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021454-001 | AB2 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021454-001 | AB2 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021454-001 | AB2 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021454-001 | AB2 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021454-001 | AB2 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021454-001 | AB2 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021454-001 | AB2 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021454-001 | AB2 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021454-001 | AB2 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | AB2 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | AB2 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | AB2 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | AB2 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021454-001 | AB2 | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021454-001 | AB2 | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021454-001 | AB2 | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021454-001 | AB2 | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021454-001 | AB2 | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021454-001 | AB2 | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021454-001 | AB2 | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021454-001 | AB2 | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021454-001 | AB2 | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021454-001 | AB2 | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N021454-001 | AB2 | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N021454-001 | AB2 | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021454-001 | AB2 | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021454-001 | AB2 | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021454-001 | AB2 | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021454-001 | AB2 | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N021454-001 | AB2 | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021454-001 | AB2 | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021454-001 | AB2 | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021454-001 | AB2 | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021454-001 | AB2 | 1 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608605 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608606 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608607 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608608 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608609 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7608610 | 2023-04-21 | U-1009 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7935690 | 2023-04-21 | U-1009 | 2011-05-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 8063029 | 2023-04-21 | U-843 | 2011-12-08 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 8178518 | 2023-04-21 | Drug product | 2012-05-15 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021454-001 | 7320968 | 2025-01-18 | U-843 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608605 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608606 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608607 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608608 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608609 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7608610 | 2023-04-21 | U-1009 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7935690 | 2023-04-21 | U-1009 | 2011-05-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 8063029 | 2023-04-21 | U-843 | 2011-12-08 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 8178518 | 2023-04-21 | Drug product | 2012-05-15 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021454-001 | 7320968 | 2025-01-18 | U-843 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608605 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608606 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608607 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608608 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608609 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7608610 | 2023-04-21 | U-1009 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7935690 | 2023-04-21 | U-1009 | 2011-05-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 8063029 | 2023-04-21 | U-843 | 2011-12-08 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 8178518 | 2023-04-21 | Drug product | 2012-05-15 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021454-001 | 7320968 | 2025-01-18 | U-843 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608605 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608606 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608607 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608608 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608609 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7608610 | 2023-04-21 | U-1009 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7935690 | 2023-04-21 | U-1009 | 2011-05-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 8063029 | 2023-04-21 | U-843 | 2011-12-08 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 8178518 | 2023-04-21 | Drug product | 2012-05-15 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021454-001 | 7320968 | 2025-01-18 | U-843 | 74a2ff9319b5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Testim
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TESTOSTERONE | 50 mg/5g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3XMK78S47O | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9f2aae1f-898d-4955-be31-678e0cf85395 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2db4fc38-a116-b0ab-3dae-57df54e5f212 | Product name | 2 | 20250121 |
| 386d1b2a-e9b7-0c83-111f-2a77b92895b3 | Product name | 5 | 20240422 |
| 7d55b53c-798b-47ae-992b-3921493a8303 | Product name | 1 | 20230322 |
| 8d753fd6-75b2-4f12-bcbf-339392960afa | Product name | 1 | 20230303 |
| 4fbda828-a5be-46fe-83ec-a88da4359919 | Product name | 1 | 20230104 |
| 93cc9bee-8bdc-273d-ec7f-c2c52535317a | Product name | 7 | 20210902 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 5 | 20210601 |
| f4f0889f-ee8b-471f-9a37-02a035280637 | Product name | 1 | 20200122 |
| 09e1afd3-f431-4380-82c5-438884c25615 | Product name | 1 | 20190111 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 3 | 20171212 |
| 502efed8-01a5-ef6a-61c6-fe8302b6e26b | Product name | 2 | 20171113 |
| 8b700cfd-17dd-41a2-90f5-a80ae8a989a2 | Product name | 1 | 20171113 |
| 9ce0e503-4ae7-2c6a-39ae-85285c29db68 | Product name | 2 | 20171113 |
| 96bdf4b3-71cd-433d-9723-89e50f852992 | Product name | 1 | 20150810 |
| ed2e617f-f28a-1df1-f9fc-c79702f31271 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66887-001-05 | Testim | 5 g in 1 TUBE | GEL | 5 | 29 | |
| 66887-001-05 | Testim | 30 in 1 CARTON | GEL | 30 | 29 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66887-001-05 | GM - Gram | 66887-001 | be3f05b3-5ebe-4511-8a86-de5d8b68b6ce | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [AUXILIUM PHARMACEUTICALS, INC.] | 14 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [AUXILIUM PHARMACEUTICALS, INC.] | 14 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [STAT RX USA] | 1 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [PHYSICIANS TOTAL CARE, INC.] | 1 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [STAT RX USA] | 1 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | TESTIM (TESTOSTERONE) GEL [PHYSICIANS TOTAL CARE, INC.] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testim | TESTOSTERONE | Endo USA, Inc. | 9f2aae1f-898d-4955-be31-678e0cf85395 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 021454 NDA021454 66887-001 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1597132 | Testim 1 % (50 MG / 5GM) Transdermal Gel | PSN | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597129 | testosterone 1 % (50 MG / 5 GM) Transdermal Gel | PSN | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597132 | 5000 MG testosterone 0.01 MG/MG Topical Gel [Testim] | SBD | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597129 | 5000 MG testosterone 0.01 MG/MG Topical Gel | SCD | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597132 | 5000 MG Testim 0.01 MG/MG Topical Gel | SY | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597132 | Testim 1 % (50 MG) Transdermal Gel, 5 GM | SY | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597129 | testosterone 50 MG Transdermal Gel, 5 GM | SY | 9f2aae1f-898d-4955-be31-678e0cf85395 | 29 |
| 1597132 | Testim 1 % (50 MG / 5GM) Transdermal Gel | PSN | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597132 | Testim 1 % (50 MG / 5GM) Transdermal Gel | PSN | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597129 | testosterone 1 % (50 MG / 5 GM) Transdermal Gel | PSN | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597129 | testosterone 1 % (50 MG / 5 GM) Transdermal Gel | PSN | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597132 | 5000 MG testosterone 0.01 MG/MG Topical Gel [Testim] | SBD | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597132 | 5000 MG testosterone 0.01 MG/MG Topical Gel [Testim] | SBD | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597129 | 5000 MG testosterone 0.01 MG/MG Topical Gel | SCD | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597129 | 5000 MG testosterone 0.01 MG/MG Topical Gel | SCD | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597132 | 5000 MG Testim 0.01 MG/MG Topical Gel | SY | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597132 | 5000 MG Testim 0.01 MG/MG Topical Gel | SY | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597132 | Testim 1 % (50 MG) Transdermal Gel, 5 GM | SY | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597132 | Testim 1 % (50 MG) Transdermal Gel, 5 GM | SY | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
| 1597129 | testosterone 50 MG Transdermal Gel, 5 GM | SY | 48f8aa83-e043-41b8-9a20-dbb098045895 | 1 |
| 1597129 | testosterone 50 MG Transdermal Gel, 5 GM | SY | 0d90cadf-d579-47bf-b655-7e9d3bd1cabe | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66887-001-05 | 66887000105 | 30 TUBE in 1 CARTON (66887-001-05) / 5 g in 1 TUBE | 30 tube | 2002-10-31 | 0000-00-00 | No | No | Current |